The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(3-Pyrrolidin-1-yl)propoxyphenyl)benzo[d]oxazole ID: ALA4074072
PubChem CID: 137641086
Max Phase: Preclinical
Molecular Formula: C20H22N2O2
Molecular Weight: 322.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2oc(-c3ccc(OCCCN4CCCC4)cc3)nc2c1
Standard InChI: InChI=1S/C20H22N2O2/c1-2-7-19-18(6-1)21-20(24-19)16-8-10-17(11-9-16)23-15-5-14-22-12-3-4-13-22/h1-2,6-11H,3-5,12-15H2
Standard InChI Key: IHBQQNCLKRHNAA-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
10.4149 -17.7616 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8951 -17.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4149 -16.4425 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6377 -16.6914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6377 -17.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9286 -17.9172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2195 -17.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2195 -16.6914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9286 -16.2828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7123 -17.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1209 -16.3893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9381 -16.3893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3467 -17.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9381 -17.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1209 -17.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1639 -17.1000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5725 -17.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3896 -17.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7982 -18.5172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6154 -18.5172 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0956 -17.8556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8728 -18.1086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8728 -18.9258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0956 -19.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
5 6 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
17 18 1 0
18 19 1 0
16 17 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
20 24 1 0
19 20 1 0
13 16 1 0
2 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 322.41Molecular Weight (Monoisotopic): 322.1681AlogP: 4.36#Rotatable Bonds: 6Polar Surface Area: 38.50Molecular Species: BASEHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.34CX LogP: 3.67CX LogD: 1.74Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: -1.52
References 1. Roy S, Mukherjee A, Paul B, Rahaman O, Roy S, Maithri G, Ramya B, Pal S, Ganguly D, Talukdar A.. (2017) Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism., 134 [PMID:28437629 ] [10.1016/j.ejmech.2017.03.086 ]